A Randomized, Open-Label, Phase III Trial of Afatinib (A) Vs Erlotinib (E) As Second-Line Treatment of Patients (Pts) with Advanced Squamous Cell Carcinoma (Scc) of the Lung Following First-Line Platinum-Based Chemotherapy: Lux-Lung 8 (Ll8)
Makaleler > Tam Makale · 2014
Yazarlar: G. Goss, E. Felip, M. Cobo, S. Lu, K.N. Syrigos, K.H. Lee, Erdem GÖKER, V. Georgoulias, W. Li, D. Isla, A. Morabito, S.Z. Guclu, Y.J. Min, A. Ardizzoni, S. Gadgeel, J. Love, V. Chand, J-C. Soria
Annals of Oncology, Uluslararası, Wos, 2014, cilt 25, ss iv426-iv426